Perspective Therapeutics, Inc. (CATX)

Perspective Therapeutics Market Cap

Perspective Therapeutics has a market cap or net worth of $266.60 million as of September 15, 2025. Its market cap has decreased by -74.07% in one year.

• Market Cap: 266.60M
• Enterprise Value: 78.60M
• 1-Year Change: -74.07%
• Ranking: #3576
• Category: Micro-Cap
• Stock Price: $3.59

Market Cap Chart

Since November 10, 2005, Perspective Therapeutics's market cap has increased from $49.80M to $266.60M, an increase of 435.35%. That is a compound annual growth rate of 8.81%.

Market Cap History

Date	Market Cap	% Change
Sep 15, 2025	266.60M	23.65%
Dec 31, 2024	215.60M	91.13%
Dec 29, 2023	112.80M	221.37%
Dec 30, 2022	35.10M	-36.18%
Dec 31, 2021	55.00M	39.95%
Dec 31, 2020	39.30M	-6.65%
Dec 31, 2019	42.10M	108.42%
Dec 31, 2018	20.20M	-8.18%
Dec 29, 2017	22.00M	-31.03%
Dec 30, 2016	31.90M	-38.18%
Dec 31, 2015	51.60M	-35.58%
Dec 31, 2014	80.10M	317.19%
Dec 31, 2013	19.20M	-28.89%
Dec 31, 2012	27.00M	41.36%
Dec 30, 2011	19.10M	-28.20%
Dec 31, 2010	26.60M	30.39%
Dec 31, 2009	20.40M	343.48%
Dec 31, 2008	4.60M	-90.09%
Dec 31, 2007	46.40M	-40.28%
Dec 29, 2006	77.70M	9.75%
Dec 30, 2005	70.80M	42.17%
Nov 10, 2005	49.80M	-

View and export this data all the way back to 2005. Sign Up Today.

Related Stocks

Company	Market Cap
Eli Lilly and Company	678.14B
Johnson & Johnson	428.83B
AbbVie	385.71B
UnitedHealth Group	319.26B
AstraZeneca	247.84B
Novo Nordisk	242.99B
Novartis AG	240.09B
Abbott Laboratories	232.75B